Cited by 149Psoriasis: Treatment and PathogenesisDermatology and Skin DiseasesCutaneous lymphoproliferative disorders research

Psoralen and Ultraviolet A Light Therapy for Psoriasis

Stern, Robert S.·2007·New England Journal of Medicine

Abstract

A 52-year-old man with psoriasis seeks treatment for his skin condition. Treatment with psoralen and ultraviolet A (PUVA) is recommended. PUVA has been used since the 1970s for the treatment of psoriasis, although few randomized studies and clinical trials comparing this treatment with no treatment or with other forms of treatment have been conducted. PUVA therapy increases the risks of both nonmelanoma skin cancer and melanoma.

Integrity signals

Registry

Crossref · 10.1056/nejmct072317

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 8-Methoxypsoralen and 5-methoxypsoralen are used in PUVA therapy for hyperproliferative skin diseases including psoriasis and vitiligo.

    “Furocoumarins including bifunctional 8-methoxypsoralen (8-MOP) and 5-methoxypsoralen (5-MOP) are still used in the so-called ''psoralen plus UVA (PUVA)'' therapy of rather frequent hyperproliferative skin diseases, including psoriasis and vitiligo (153-155).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stern, R. S.
Affiliations
Beth Israel Deaconess Medical Center (US)
Corresponding author
Stern, Robert S.
Venue
New England Journal of Medicine
Published
2007-08-16
Volume
357
Issue
7
Pages
682-690
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1989894409
Cited by
149
References
48
Citations by year
2026: 3 · 2025: 2 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 9 · 2018: 9 · 2017: 6 · 2016: 10 · 2015: 7 · 2014: 7 · 2013: 11 · 2012: 9
FWCI
0.85
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Cutaneous lymphoproliferative disorders research
Keywords
psoriasis, psoralen, UVA, PUVA therapy, phototherapy, non-melanoma skin cancer, melanoma risk, treatment risks
MeSH terms
Ficusin, Humans, Male, Middle Aged, Psoriasis, PUVA Therapy, Skin, Photosensitizing Agents, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review